|
|
|
|
The goal of the prostate cancer screening is to discover cancer before symptoms arise. Discovering prostate cancer at early stages greatly increases the survival rate of the patient. Common prostate cancer screening methods are as follows: PSA (Prostate-Specific Antigen) value: PSA is a protein produced by the prostate gland. PSA can be measured by taking a blood test. It is normal for men to have a low amount of PSA in the blood. However, elevated PSA values signify possible issues with the prostate, including prostate cancer. The range of PSA values is usually defined as follows:
PSA values by itself is not necessarily a good indicator for the presence of prostate cancer, as many factors can lead to elevated PSA values. Digital Rectal Examination (DRE): The doctor will insert his/her fingers into the rectum to feel any abnormalities on the prostate. Biopsy: If prostate cancer is suspected as the result of PSA value and Digital Rectal Examination, a biopsy, in which tissues are taken from the prostate and examined, is performed. The biopsy should give the doctor a good idea whether prostate cancer is present, and what stage the cancer is in.
Copyright 2008 cancer-resource.net. All Rights Reserved. Privacy Policy |
|